Continental Investment Partners, Independent sponsor of private equity transactions with a focus on the biomedical sector, through its Healthcare Capital Partners VII SCSp fund, has completed the acquisition of the Gruppo AlfaMed, a leading operator in the medical-surgical, biomedical and electromedical devices sector, headquartered in the Marche region, in Porto San Giorgio.

The transaction involved the acquisition of 100% of AlfaMed S.r.l., 100% of AlfaMed International Sagl and 25% of MDE S.r.l., and was structured through Caesar BidCo S.r.l., a special purpose vehicle incorporated for the acquisition of the AlfaMed Group, in which Continental Investment Partners holds a 65% equity interest, while the founding shareholders, Alessandro Alessandrini and Stefano Sabbatini, reinvested part of the consideration by acquiring the remaining 35% of the share capital.

This ownership structure is intended to ensure the operational and managerial continuity of the Group.

The transaction was also completed with the support of a syndicated financing, coordinated by Iccrea Banca S.p.A. as mandated lead arranger and agent bank, together with Banca del Piceno Società Cooperativa and Banca del Fucino S.p.A.

BLF Studio Legale advised the purchaser on all legal aspects of the transaction, with a team comprising partners Giulio Pinetti e Andrea Corbelli dal senior associate Davide Geraci e dall’associate Gaetano Ruvolo.